Leading Croatian pharmaceutical producer Pliva -- which was recently acquired by US-based Barr Pharmaceutical -- reported a 12% decrease in its overall revenues from January-September.
Vodeći hrvatski farmaceutski proizvođač Pliva -- koju je nedavno kupila američka kompanija Bar Farmaseutikal -- prijavila je smanjenje ukupnih prihoda od 12 odsto u periodu januar-septembar.